• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » COVID-19

COVID-19
COVID-19 RSS Feed RSS

COVID-19 Update

September 21, 2020
COVID-19 Drug Research Roundup Read More

Drugmakers Pledge Science over Speed in Vaccine Trials

September 14, 2020
The CEOs of nine pharmaceutical companies racing to develop COVID-19 vaccines made an unprecedented pledge last week to “uphold the integrity of the scientific process” in the trials they are conducting for vaccine approval. Read More

AstraZeneca Halts Phase 3 Vaccine Trial over Possible Serious Adverse Reaction

September 14, 2020
AstraZeneca has paused a late-stage trial of its promising COVID-19 vaccine candidate while it evaluates a single UK patient who may have experienced a serious adverse reaction. Read More

COVID-19 Update

September 14, 2020
COVID-19 Drug Research Roundup Read More
BurdeninGray-360x240.png

Sites Overwhelmed by Cost and Trial Complexity, Need Sponsor Help to Bear the Burden

September 14, 2020
Leslie Ramsey
Dwindling clinical trial financial resources caused by COVID-19 and declining investigator participation are clashing with sponsors’ demand for more — and more complex — trials, creating a “perfect storm” of pressure that threatens to overwhelm the research industry if sites and sponsors don’t work together to adjust to the realities of life in a pandemic. Read More

Biotech CEOs Publish Open Letter on FDA Independence and COVID-19 Trial Transparency

September 7, 2020
In an open letter by the Biotechnology Innovation Organization (BIO) published last week, a group of biotech CEOs argued that political considerations should be put aside by both major political parties and the conclusions about the safety and efficacy of COVID-19 therapies should only be based on rigorous data collection and assessment by appropriate bodies. Read More

FDA Updates Guidance on COVID-19 Convalescent Plasma Use

September 7, 2020
The FDA has updated its guidance on the use of convalescent plasma to treat COVID-19 or in clinical trials of the treatment to take account of the Trump administration’s Aug. 23 Emergency Use Authorization (EUA). Read More

COVID-19 Update

September 7, 2020
COVID-19 Drug Research Roundup Read More

Investigators Concerned Fewer Patients With COVID-19 Will Enroll in Plasma Studies

August 31, 2020
The FDA’s decision to grant Emergency Use Authorization (EUA) for convalescent plasma in patients with COVID-19 has led many investigators to voice concerns that not enough patients with the infection will enroll in randomized controlled trials of the therapy going forward. Read More

COVID-19 Update

August 31, 2020
COVID-19 Drug Research Roundup Read More
Previous 1 2 … 6 7 8 9 10 11 12 13 14 … 21 22 Next

Upcoming Events

  • 15Sep

    Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis

  • 21Sep

    The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval

  • 16Oct

    WCG MAGI's Clinical Research Conference 2022 West

  • 16Nov

    17th Annual FDA Inspections Summit

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Options-360x240.png

    Cancer Patients Signal Interest in Less Travel, More Remote Trial Options

  • SurveywBlueBackground-360x240.png

    New Study Shows Trends in Funding, Racial Balance Amidst COVID-19

  • Complexity-360x240.png

    Rising Trial Complexities Create More Payment Problems, Frustrations for Sites

  • Challenge-360x240.png

    BYOD Trials Growing in Popularity, But Unique Tech Challenges Remain

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing